Hawkins Inc
HWKN
132.38
+0.13
+0.10%
Hawkins Inc
US · HWKN
#2566 by market cap
Listed 1970
132.38
+0.13
+0.10%
Live - 5344 symbols - heartbeat 138s ago
· 2026-10-08 07:34
Pre-market
131.66
-0.54%
After-hours
132.38
0.00%
- Market cap
- 2.76B
- P/E (TTM)i
- 34.30
- P/Bi
- 5.04
- EPSi
- 3.91
- Div yieldi
- 0.57%
- 52W posi
- 27%
Reader sentiment
Are you bullish or bearish on HWKN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.03, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.21% YoY
Margins
- Gross margin
- 22.61%
- Operating margin
- 11.19%
- Net margin
- 7.53%
Key ratios & quality
- Enterprise valuei
- 3.01B
- PEG ratioi
- 3.19
- Altman Z-Scorei
- 6.03
PEG uses trailing P/E against the 3-year net income growth rate (10.74%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 556.33M | 540.20M | 596.87M | 774.54M | 935.10M | 919.16M | 974.43M | 1.08B |
| Gross profit | 95.94M | 100.92M | 123.76M | 146.52M | 165.12M | 193.64M | 225.54M | 245.06M |
| Selling & admin expenses | 59.12M | 59.25M | 67.88M | 75.33M | 76.97M | 89.60M | 106.36M | 123.76M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 36.82M | 41.67M | 55.88M | 71.19M | 88.15M | 104.04M | 119.17M | 121.29M |
| Pretax profit | 33.53M | 38.96M | 55.85M | 69.98M | 82.58M | 101.15M | 114.38M | 109.34M |
| Tax | 9.10M | 10.59M | 14.87M | 18.44M | 22.54M | 25.78M | 30.04M | 27.79M |
| Net profit | 24.43M | 28.37M | 40.98M | 51.54M | 60.04M | 75.36M | 84.35M | 81.55M |
| Basic EPS | 1 | 1 | 2 | 2 | 3 | 4 | 4 | 4 |
| Diluted EPS | 1.14 | 1.33 | 1.93 | 2.44 | 2.86 | 3.59 | 4.03 | 3.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 245.32M | 293.27M | 280.43M | 244.08M | 265.91M | 315.68M |
| Gross profit | 52.24M | 72.36M | 67.64M | 50.81M | 54.24M | 74.01M |
| Selling & admin expenses | 27.66M | 31.03M | 33.70M | 28.26M | 30.77M | 35.34M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 24.58M | 41.33M | 33.94M | 22.56M | 23.46M | 38.67M |
| Pretax profit | 22.42M | 39.01M | 30.83M | 19.58M | 19.92M | 37.32M |
| Tax | 6.10M | 9.83M | 8.23M | 5.27M | 4.46M | 9.07M |
| Net profit | 16.33M | 29.18M | 22.60M | 14.31M | 15.46M | 28.25M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.78 | 1.40 | 1.08 | 0.69 | 0.74 | 1.35 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 139.41M | 131.03M | 163.01M | 227.74M | 232.04M | 202.83M | 230.69M | 231.47M |
| Cash & ST investments | 9.20M | 4.28M | 3.00M | 3.50M | 7.57M | 7.15M | 5.10M | 3.91M |
| Inventory | 60.48M | 54.44M | 63.86M | 94.99M | 88.78M | 74.60M | 83.51M | 78.20M |
| Total assets | 385.60M | 389.33M | 472.55M | 567.33M | 590.54M | 657.93M | 770.05M | 986.29M |
| Total current liabilities | 55.40M | 62.22M | 70.46M | 101.47M | 90.87M | 103.31M | 97.22M | 104.84M |
| Short-term debt | 9.91M | 11.43M | 11.49M | 9.91M | 9.91M | 9.91M | 2.90M | 3.00M |
| Long-term debt | 74.66M | 49.75M | 88.85M | 115.64M | 101.73M | 88.82M | 149.00M | 244.00M |
| Total liabilities | 167,738,000.00 | 155,844,000.00 | 207,304,000.00 | 264,727,000.00 | 240,519,000.00 | 251,908,000.00 | 309,756,000.00 | 452,281,000.00 |
| Total equity | 217.86M | 233.48M | 265.25M | 302.60M | 350.02M | 406.03M | 460.29M | 534.01M |
| Retained earnings | 164.41M | 182.95M | 213.90M | 254.38M | 302.42M | 364.55M | 434.26M | 500.14M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 230.69M | 256.42M | 239.56M | 228.20M | 231.47M | 248.78M |
| Cash & ST investments | 5.10M | 14.50M | 10.42M | 8.21M | 3.91M | 7.98M |
| Inventory | 83.51M | 95.72M | 92.91M | 85.93M | 78.20M | 79.86M |
| Total assets | 770.05M | 988.27M | 984.16M | 976.53M | 986.29M | 1.01B |
| Total current liabilities | 97.22M | 110.93M | 98.56M | 97.16M | 104.84M | 109.61M |
| Short-term debt | 2.90M | 9.81M | 9.81M | 9.81M | 3.00M | 2.96M |
| Long-term debt | 149.00M | 288.28M | 268.33M | 253.38M | 244.00M | 244.00M |
| Total liabilities | 309,756,000.00 | 503,702,000.00 | 477,196,000.00 | 457,620,000.00 | 452,281,000.00 | 458,039,000.00 |
| Total equity | 460.29M | 484.57M | 506.97M | 518.91M | 534.01M | 548.20M |
| Retained earnings | 434.26M | 459.68M | 478.31M | 488.65M | 500.14M | 524.43M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 47.99M | 58.90M | 43.79M | 42.84M | 77.40M | 159.50M | 111.10M | 144.33M |
| Depreciation & amortization | 21.76M | 21.58M | 22.67M | 24.13M | 27.44M | 31.80M | 39.95M | 52.54M |
| Free cash flow | 35.37M | 34.35M | 23.00M | 14.33M | 29.08M | 119.35M | 70.00M | 86.09M |
| Dividends paid | -11.98M | -9.83M | -10.03M | -11.06M | -12.00M | -13.24M | -14.64M | -15.67M |
| Stock buybacks / issuance | -3.28M | -4.80M | -2.61M | -8.24M | -6.10M | -11.17M | -20.56M | 12.00K |
| Ending cash balance | 9.20M | 4.28M | 3.00M | 3.50M | 7.57M | 7.15M | 5.10M | 3.91M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 30.84M | 31.49M | 39.54M | 35.56M | 37.74M | 35.15M |
| Depreciation & amortization | 10.58M | 12.29M | 13.26M | 13.41M | 13.58M | 13.95M |
| Free cash flow | 19.76M | 17.95M | 28.74M | 21.24M | 18.16M | 23.55M |
| Dividends paid | -3.75M | -3.75M | -3.97M | -3.97M | -3.97M | -3.97M |
| Stock buybacks / issuance | -12.71M | 0 | 1.61M | 0 | -1.60M | -7.02M |
| Ending cash balance | 5.10M | 14.50M | 10.42M | 8.21M | 3.91M | 7.98M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.63 | 12.57 | 16.43 | 18.15 | 18.40 | 19.94 | 19.47 | 16.40 |
| ROA %i | 6.29 | 7.32 | 9.51 | 9.91 | 10.37 | 12.07 | 11.81 | 9.29 |
| ROIC %i | 8.88 | 9.99 | 12.40 | 12.91 | 14.04 | 15.96 | 15.58 | 12.95 |
| 5-year avg ROE %i | 7.49 | 7.96 | 9.41 | 10.88 | 15.44 | 17.10 | 18.48 | 18.47 |
| EBIT margin %i | 6.63 | 7.68 | 9.60 | 9.22 | 9.39 | 11.47 | 12.30 | 11.34 |
| FCF / sales %i | 6.36 | 6.36 | 3.85 | 1.85 | 3.11 | 12.98 | 7.18 | 7.94 |
| Current ratioi | 2.52 | 2.11 | 2.31 | 2.24 | 2.55 | 1.96 | 2.37 | 2.21 |
| Quick ratioi | 1.33 | 1.15 | 1.33 | 1.24 | 1.51 | 1.18 | 1.44 | 1.38 |
| Debt / assetsi | 21.93 | 17.68 | 23.40 | 23.74 | 20.38 | 16.45 | 21.14 | 26.51 |
| LT debt / equityi | 34.27 | 24.58 | 37.35 | 41.24 | 31.55 | 24.22 | 34.74 | 48.40 |
| Interest coveragei | 10.98 | 16.51 | 39.07 | 50.84 | 16.78 | 24.62 | 22.06 | 9.10 |
| Revenue CAGR (3Y) %i | 10.35 | 3.76 | 5.79 | 11.66 | 20.07 | 15.48 | 7.95 | 5.04 |
| Net income CAGR (3Y) %i | 10.43 | 7.94 | -- | 28.25 | 28.39 | 22.52 | 17.84 | 10.74 |
| FCF CAGR (3Y) %i | 42.79 | 13.92 | 44.35 | -26.01 | -5.40 | 73.13 | 69.69 | 43.59 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.47 | 18.69 | 17.49 | 16.89 | 16.40 | 15.61 |
| ROA %i | 11.81 | 10.01 | 9.93 | 9.79 | 9.29 | 8.08 |
| ROIC %i | 15.58 | 13.27 | 13.32 | 13.25 | 12.95 | 11.28 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.30 | 12.07 | 11.71 | 11.65 | 11.34 | 10.91 |
| FCF / sales %i | 7.18 | 8.01 | 7.54 | 8.25 | 7.94 | 8.29 |
| Current ratioi | 2.37 | 2.31 | 2.43 | 2.35 | 2.21 | 2.27 |
| Quick ratioi | 1.44 | 1.39 | 1.44 | 1.36 | 1.38 | 1.46 |
| Debt / assetsi | 21.14 | 31.23 | 29.80 | 28.50 | 26.51 | 25.90 |
| LT debt / equityi | 34.74 | 61.67 | 55.91 | 51.74 | 48.40 | 47.01 |
| Interest coveragei | 22.06 | 16.42 | 12.43 | 10.27 | 9.10 | 9.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Water treatment is the largest reported line at 50.14% of revenue, across 3 reported segments.
- Industrial solutions follows at 30.81%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Water treatment50.14%
Industrial solutions30.81%
Food & Health Sciences19.05%
Quote time 2026-10-08 07:34:31 · For reference only, not investment advice and not tailored to your situation.